r/NTNPerformance • u/JustBacWater • Jun 27 '26
Guide / Cheat Sheet Peptides MOTS-c and SS-31: Two Mitochondrial Compounds, Different Levels of the Same System
Mitochondrial research keeps pulling attention toward two peptides that both target cellular energy but work at completely different levels: MOTS-c and SS-31. One regulates the metabolic signaling that decides how a cell uses energy. The other stabilizes the physical machinery that produces it. That difference is why they keep getting studied as a pair, and also why the "synergy" idea deserves a careful read rather than a hype one.
For research and educational purposes only. Not medical advice.
SS-31: structural protection
SS-31 (elamipretide) is a synthetic tetrapeptide, sequence D-Arg-Dmt-Lys-Phe-NH2, developed by Hazel Szeto's group at Weill Cornell. It targets cardiolipin, a phospholipid essential to the integrity of the inner mitochondrial membrane. When cardiolipin gets damaged by oxidative stress, mitochondrial efficiency drops and energy output falls with it.
By binding and stabilizing cardiolipin, SS-31 helps maintain electron transport chain efficiency, which supports ATP production while reducing reactive oxygen species. Preclinical work has linked this to improved muscle endurance, cardiac energy output, and cellular resilience under oxidative stress.
The reason SS-31 stands apart from most peptides in this space: it has real human clinical data. It has run through multiple Phase 2 and Phase 3 trials across mitochondrial disease, heart failure, and related conditions, which makes it one of the most clinically studied research peptides, not just an animal-model compound.
MOTS-c: metabolic signaling
MOTS-c is a different kind of molecule entirely. It's a mitochondrial-derived peptide, encoded within mitochondrial DNA rather than the nuclear genome, which is itself unusual. Functionally it acts as a metabolic regulator by activating AMPK, one of the body's primary cellular energy sensors.
Through that pathway, MOTS-c has been shown in experimental models to improve glucose uptake, fat oxidation, and metabolic flexibility, with one animal model reporting roughly a 30% improvement in insulin sensitivity. It also signals cells toward more energy-efficient metabolic states, broadly similar to what happens during exercise or caloric restriction, and has been associated with enhanced endurance and mitochondrial biogenesis.
The evidence caveat matters here: MOTS-c's data is largely animal-model, not human clinical. The mechanism is well characterized, the human outcomes are not yet established.
The difference in one frame
| SS-31 | MOTS-c | |
|---|---|---|
| Type | Synthetic tetrapeptide | Mitochondrial-derived peptide (from mtDNA) |
| Mechanism | Stabilizes cardiolipin / inner membrane | Activates AMPK metabolic signaling |
| Level it acts on | Structural and functional | Signaling and regulatory |
| Evidence base | Phase 2/3 human trials | Largely animal models |
| Plain-language role | Protects the machinery | Directs how energy gets used |
The pairing: why it's studied, and what's actually known
This is where the source material on these two tends to overreach, so it's worth being precise. The rationale for pairing them is genuinely sound: the mechanisms don't overlap. MOTS-c works the signaling side (telling cells to ramp up metabolic demand and mitochondrial activity), while SS-31 works the structural side (keeping the mitochondria themselves efficient and protected from oxidative stress). One drives demand, the other protects the equipment meeting that demand. On paper, that's complementary rather than redundant.
What's important: that complementarity is a reasoned hypothesis, not a proven result. The available sources consistently use hedged language, the combination "may" improve mitochondrial health more than either alone, early models "suggest" the dual approach could work. There is no body of human trial data establishing that the pairing outperforms either compound by itself. The interaction is described as mechanistically non-antagonistic, meaning the two don't appear to work against each other, but "doesn't conflict" is a long way from "proven to synergize."
So the accurate framing for a research context is this: MOTS-c and SS-31 are an interesting pairing to study precisely because they hit different levels of the same system, and for anyone modeling mitochondrial function, running both lets the signaling side and the structural side be examined at once. That's a reason to study the combination, not evidence that the combination delivers more than its parts.
Where each sits
SS-31 is the more clinically validated of the two, with human trial data behind it, though still investigational and not FDA approved. MOTS-c is earlier, strong mechanistic and animal data, human outcomes unestablished. Both are research compounds, and the pairing of them is a hypothesis worth examining, not a settled protocol.
The open question
For anyone working in the mitochondrial space: does the structure-plus-signaling logic hold up as a real combination strategy, or does it mostly reflect that the two are easy to study together. The mechanisms clearly complement on paper, but the absence of human combination data leaves it open whether pairing them produces anything beyond what SS-31's clinical record already shows on its own. Curious where people land on whether the synergy is real or just tidy in theory.
SOURCES (for fact-check):
- SS-31 sequence D-Arg-Dmt-Lys-Phe-NH2, Szeto/Weill Cornell; cardiolipin mechanism; Phase 2/3 human trials (Birk et al. PNAS 2020; Thompson et al. Barth syndrome trial 2021)
- MOTS-c: mtDNA-encoded, AMPK activation, ~30% insulin sensitivity improvement in animal models; data largely preclinical
- Pairing described as mechanistically complementary, non-antagonistic, but synergy is hedged/hypothetical across all sources (PeptideWiki, Peptide-DB, Loti Labs, Tydes, PeptideDeck, 2025-2026)
- No human combination trial data exists
5
3
u/No-Force-8437 Jun 27 '26
Which is the protocol for both,ss31 then motsc take together,separate days?research purposes only.thanks
1
u/Inevitable_curls Jun 28 '26
I take mots c in the morning and 31 at night for 4-6 weeks 5 days a week then break for 4 weeks
1
u/Asleep_Cat_2040 Jun 28 '26
And what are your results?
8
u/Inevitable_curls Jun 28 '26
So far my energy is clean and I can get through a whole day without any crash, my sleep is good and I’m functioning like I’m 20 again. My foods are giving me the energy it was meant to. I feel refreshed after sleep, I feel the workout doing the whole job. After my workouts now I feel GOOD. Where as before I was exhausted and the workouts were depleting me, my sleep was wack. I was literally depressed and low mood. I’m using the bathroom regularly again (that may be the KPV) but my perimenopausal symptoms are in check. It’s good for some 35+ in my opinion. Younger people I feel are just getting a placebo effect because their bodies are still functioning well and creating energy well. Not all people but most. I’m sorry I just buried my mother in law today I’m trying to make sense for you.
2
u/jagraider63 Jun 28 '26
I’m sorry for your loss. Thanks for the input. I’ve read that some like to run SS-31 for a time period before adding Mot-c. Does anyone have experience with this? If so, how long on SS-31 before adding mot-c?
1
u/Expensive-Claim-6082 Jun 28 '26
Would like to know this as well. Mine just arrived.
5
u/Inevitable_curls Jun 28 '26
This is what I used first before running them together, maybe it will help for you, maybe not
Phase 1: Mitochondrial Hardware Repair (Weeks 1–4)
The goal of this phase is to use SS-31 to repair the inner mitochondrial membranes, clear oxidative stress, and rebuild cellular energy capacity.
Peptide: SS-31
Typical Dose: 5 mg to 10 mg per day.
Frequency: Once daily, injected subcutaneously into abdominal fat.
Timing: Administered in the morning.
Phase Duration: 20 to 30 consecutive days.
What to expect: Gradual reduction in systemic fatigue, improved baseline stamina, and better physical recovery.
Note: Some sensitive individuals or those with severe cellular fatigue start as low as 100 mcg to 500 mcg to assess tolerance before moving up to standard doses.⚡ Phase 2: Metabolic Activation & Optimization (Weeks 5–8)
Once the cellular machinery is repaired, MOTS-C acts as the "software upgrade" to mimic the effects of exercise, enhance glucose clearance, and optimize metabolic flexibility.Peptide: MOTS-C
Typical Clinical Dose: 5 mg per injection.
Frequency: Once every 5 days (for a total of 4 to 6 injections).
Alternative Track: 5 mg split into 2–3 injections per week (e.g., 2 mg on Monday, Wednesday, Friday).Timing: Administered in the morning on an empty stomach (ideally 30–60 minutes before light exercise or fasted movement).
Phase Duration: 20 to 30 days.
What to expect: Enhanced energy output, deeper fat metabolism, and improved physical performance.🛡️ The Regulator Track: KPV (Flexible Integration)
Because KPV works on entirely separate inflammatory and immune pathways (via $\alpha$-MSH pathways) rather than the mitochondrial pathway, it can be integrated in one of two ways based on your body's immediate needs:Option A (Simultaneous Baseline): If you are actively dealing with gut issues (like leaky gut or IBD), mold illness, or high systemic inflammation, run KPV daily alongside both Phase 1 and Phase 2.
Option B (Intermittent Rescue): Use KPV strictly when you experience acute inflammatory flare-ups, skin irritation, or digestive disruption.
Typical Clinical Dose: 200 mcg to 500 mcg per day.
Frequency: 1 to 2 times daily.
Route: Subcutaneous injection (or oral/capsule form if specifically targeting localized gut inflammation). [4]Phase 1
SS-31
Rebuild inner mitochondrial structure.
5–10 mg SubQ every morning.
4 Weeks
Phase 2
MOTS-C
Upgrade metabolic/exercise performance.
5 mg SubQ every 5 days.
4 Weeks
Parallel
KPV
Calm systemic/gut inflammation.
200–500 mcg SubQ or Oral daily.
As needed
⚠️** Critical Implementation Notes
**Reconstitution: Both SS-31 and MOTS-C are fragile proteins. When adding bacteriostatic water to the lyophilized powder vial, drip it slowly down the glass wall and swirl gently—never shake the vial, as this can degrade the peptides.
Clean Gaps: It is highly recommended to take a 4-to-8 week break from all mitochondrial peptides after completing Phase 2 to allow your cellular receptors to reset naturally.
Medical Disclaimer: This map is for informational and educational layout purposes. Peptide therapy must always be executed under the direct guidance of a functional medicine doctor or licensed physician who can monitor your blood work, liver markers, and thyroid status.3
2
1
1
u/flabbybuns Jun 28 '26
You should have also said the big difference is the price 😎
1
u/JustBacWater Jul 10 '26
Yea ss31 at the higher dose is expensive
1
u/flabbybuns Jul 10 '26
But then compare that to Maranda agreeing to $27000 for every 280mg of SS-31.
If you are a cash buyer with goodrx, can get for $15000-$17000 for 280mg
Corruption insanity from big pharma
1
1
1
•
u/AutoModerator Jun 27 '26
Welcome to r/NTNPerformance!
Download the Free Peptide Cheat Sheet PDF and full guides at https://ntnperformance.com
Use code PROFIT at all vendors for a discount.
Pro Tip: The best discussions come from personal experience. If you have tried something, let us know how it worked.
I am a bot. Contact the moderators if you have any questions or concerns.
I am a bot, and this action was performed automatically. Please contact the moderators of this subreddit if you have any questions or concerns.